“…hSC-CMs have been shown to display cellular electrophysiological properties that are often similar to human primary cardiomyocytes, including ionic currents, channel gating properties, ventricular-like action potentials, and expected sensitivity to multiple drugs (Bett, et al, 2013;Honda, Kiyokawa, Tabo, & Inoue, 2011;Ma, et al, 2011;Peng, Lacerda, Kirsch, Brown, & Bruening-Wright, 2010). A variety of approaches have been utilized in hSC-CM based assays, including patch clamp, microlectrode arrays, optical indicators of voltage, mechanical movement, cellular impedance, Ca 2+ transients and others (Ando, et al, 2017; A C C E P T E D M A N U S C R I P T -6 -Asakura, et al, 2015;Blinova, et al, 2017;Gossmann, et al, 2016;Guo, et al, 2011;Guo, et al, 2013;Kitaguchi, et al, 2017;Leyton-Mange, et al, 2014;Lu, et al, 2017;Lu, et al, 2015;Nunes, et al, 2013;Pfeiffer, et al, 2016;Pfeiffer, et al, 2017;Piccini, Rao, Seebohm, & Greber, 2015;Puppala, et al, 2013;Scott, et al, 2014;Sirenko, et al, 2013;Sun & Nunes, 2016;Zeng, Roman, Lis, Lagrutta, & Sannajust, 2016). These studies have provided promising evidence that hSC-CMs are a relevant cell model to study drug-induced cardiac abnormalities, including arrhythmia and QT prolongation, and display good in vitro concordance to clinical findings.…”